E-cigarettes helped more smokers quit than nicotine replacement therapyBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2036 (Published 10 May 2019) Cite this as: BMJ 2019;365:l2036
- Rob Cook, clinical director1,
- Peter Davidson, clinical adviser2,
- Rosie Martin, clinical specialist1
- on behalf of NIHR Dissemination Centre
- 1Bazian, Economist Intelligence Unit healthcare, London, UK
- 2Wessex Institute, University of Southampton, Southampton, UK
- Correspondence to R Cook
Hajek P, Phillips-Waller A, Przulj D, et al. A randomised trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019;380:629-37.
This trial was funded by the NIHR Health Technology Assessment Programme (12/167/135) and by Cancer Research UK.
To read the full NIHR Signal, go to https://discover.dc.nihr.ac.uk/content/signal-000757/e-cigarettes-helped-more-smokers-quit-than-nicotine-replacement-therapy
Competing interestsThe BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of the BMJ policy on financial interests is here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests
Contributors Anna Sayburn
All authors contributed to the development and review of this summary, as part of the wider NIHR Signals editorial team (https://www.bmj.com/NIHR-signals). RC is guarantor.
Disclaimer NIHR Signals are owned by the Department of Health and Social Care and are made available to the BMJ under licence. NIHR Signals report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Signals.
Permission to reuse these articles should be directed to email@example.com.